Contact Us Scientific Committees Pharmacogenetics Committee
Vice-Chair
Nicholas Picard Limoges, France
Background & Purpose of the Committee
To promote the knowledge about clinically relevant DNA testing to optimize drug therapy
To enhance the translation of research into clinical practice
To encourage discussions on the clinical relevance of specific pharmacogenetics tests, to encourage research into clinically important areas with respect to drug treatment
To encourage interaction between pharmacologist and toxicologist to promote “toxicogenetics”
Committee Initiatives for 2018/2019
Make proposal for IATDMCT PGx session in Foz Do Iguassu, Brazil, 2019
Propose/validate a (minimal) NGS panel to be used for pharmacogenetic applications in the field of TDM and CT (to be published in IATDMCT Compass)
Explore the need for updated PGx guidelines in immunosuppressive therapy
Committee Initiatives Completed in 2016/2017
Informed members of IATDMCT on current discussions regarding PGx testing, on new potentially interesting pharmacogenetic markers, and the emergence of new technologies.
Represented IATDMCT in IFCC, AACC, EFLM, IUPHAR and ESPT for initiatives on PGx.
Advised IATDMCT Rotterdam committee on scientific program regarding PGx